Valuation KDventures AB OTC Markets
Stocks
KDEVF
SE0002190926
Medical Equipment, Supplies & Distribution
|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 08-03 | Umecrine Cognition has enrolled the last patient in study | FW |
| 07-09 | KD Ventures portfolio company PharmNovo raises SEK 39m | FW |
Company Valuation: KDventures AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 315.8 | 933.2 | 466.8 | 458.2 | 257.2 | 117.6 |
| Change | - | 195.56% | -49.98% | -1.85% | -43.88% | -54.25% |
| Enterprise Value (EV) 1 | 316.5 | 966.2 | 277.7 | 376 | 217.3 | 94.85 |
| Change | - | 205.3% | -71.25% | 35.37% | -42.22% | -56.34% |
| P/E | -1.52x | 5.48x | -5.05x | 85.1x | -31.7x | -0.61x |
| PBR | 0.39x | 0.96x | 0.38x | 0.37x | 0.21x | 0.11x |
| PEG | - | -0x | 0x | -1x | 0x | -0x |
| Capitalization / Revenue | 119x | 430x | 203x | 227x | 140x | 70.4x |
| EV / Revenue | 119x | 445x | 121x | 187x | 118x | 56.8x |
| EV / EBITDA | -10.8x | -34.6x | -8.94x | -14x | -7.15x | -4.77x |
| EV / EBIT | -10.5x | -33.8x | -8.74x | -13.6x | -6.92x | -4.54x |
| EV / FCF | -5.71x | 55.3x | -7.61x | -31.6x | -11x | -5.62x |
| FCF Yield | -17.5% | 1.81% | -13.1% | -3.17% | -9.06% | -17.8% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.183 | 0.97 | -0.3423 | 0.02 | -0.03 | -0.72 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 2.651 | 2.17 | 2.3 | 2.014 | 1.838 | 1.671 |
| EBITDA 1 | -29.44 | -27.92 | -31.08 | -26.78 | -30.38 | -19.88 |
| EBIT 1 | -30.12 | -28.61 | -31.77 | -27.58 | -31.38 | -20.88 |
| Net income 1 | -207.5 | 170.8 | -88.12 | 5.386 | -8.101 | -193.9 |
| Net Debt 1 | 0.706 | 32.93 | -189.1 | -82.2 | -39.9 | -22.8 |
| Reference price 2 | 1.8000 | 5.3200 | 1.7300 | 1.6980 | 0.9530 | 0.4360 |
| Nbr of stocks (in thousands) | 175,421 | 175,421 | 269,833 | 269,833 | 269,833 | 269,833 |
| Announcement Date | 3/25/21 | 3/25/22 | 3/24/23 | 3/22/24 | 3/21/25 | 3/20/26 |
1SEK in Million2SEK
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 31.92x | 4.3x | 16.65x | 2.31% | 193B | |
| 20.52x | 3.56x | 12.5x | 3.28% | 116B | |
| 16.98x | 0.2x | 12.29x | 0.77% | 59.16B | |
| 32.4x | 8.09x | 20.64x | 1.23% | 55.75B | |
| 35.07x | 3.39x | 11.63x | 2.16% | 49.57B | |
| 36.67x | 6.45x | 20.26x | -.--% | 34.52B | |
| 46.3x | 1.32x | 12.04x | 0.16% | 31.22B | |
| 40.37x | 7.07x | 25.37x | 0.26% | 24.36B | |
| 20.68x | 3.14x | 11.72x | 1.4% | 24.25B | |
| Average | 31.21x | 4.17x | 15.90x | 1.29% | 65.26B | |
| Weighted average by Cap. | 29.41x | 4.06x | 15.47x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- KDV B Stock
- KDEVF Stock
- Valuation KDventures AB
Select your edition
All financial news and data tailored to specific country editions
